D. Hildick-Smith

Publications188
h-index44
Citations7,976
Highly Influential Citations261
Claim Author Page
Author pages are created from data sourced from our academic publisher partnerships and public sources.

Recommended Authors

  • J. Webb
  • 758 Publications, 58,726 Citations
  • S. Windecker
  • 1,212 Publications, 77,356 Citations
  • M. León
  • 1,744 Publications, 127,405 Citations
  • A. Colombo
  • 1,737 Publications, 66,637 Citations
  • Publications
  • Influence
Patent Foramen Ovale Closure or Antiplatelet Therapy for Cryptogenic Stroke
BACKGROUND The efficacy of closure of a patent foramen ovale (PFO) in the prevention of recurrent stroke after cryptogenic stroke is uncertain. We investigated the effect of PFO closure combined with… Expand
  • 441
  • 23
  • PDF
Percutaneous closure of patent foramen ovale in cryptogenic embolism.
BACKGROUND The options for secondary prevention of cryptogenic embolism in patients with patent foramen ovale are administration of antithrombotic medications or percutaneous closure of the patent… Expand
  • 668
  • 22
  • PDF
Transcatheter aortic valve implantation in failed bioprosthetic surgical valves.
IMPORTANCE Owing to a considerable shift toward bioprosthesis implantation rather than mechanical valves, it is expected that patients will increasingly present with degenerated bioprostheses in the… Expand
  • 559
  • 19
  • PDF
Transcatheter Aortic Valve Replacement for Degenerative Bioprosthetic Surgical Valves: Results From the Global Valve-in-Valve Registry
Background— Transcatheter aortic valve-in-valve implantation is an emerging therapeutic alternative for patients with a failed surgical bioprosthesis and may obviate the need for reoperation. We… Expand
  • 403
  • 14
A prospective randomized evaluation of the TriGuard™ HDH embolic DEFLECTion device during transcatheter aortic valve implantation: results from the DEFLECT III trial.
AIMS To evaluate the safety, efficacy, and performance of the TriGuard™ HDH Embolic Deflection Device (TriGuard) compared with no cerebral protection in patients undergoing transcatheter aortic valve… Expand
  • 177
  • 14
Outcomes in Transcatheter Aortic Valve Replacement for Bicuspid Versus Tricuspid Aortic Valve Stenosis.
BACKGROUND Transcatheter aortic valve replacement (TAVR) is being increasingly performed in patients with bicuspid aortic valve stenosis (AS). OBJECTIVES This study sought to compare the procedural… Expand
  • 185
  • 9
  • PDF
Migraine Intervention With STARFlex Technology (MIST) Trial: A Prospective, Multicenter, Double-Blind, Sham-Controlled Trial to Evaluate the Effectiveness of Patent Foramen Ovale Closure With…
Background— Patent foramen ovale (PFO) is prevalent in patients with migraine with aura. Observational studies show that PFO closure resulted in migraine cessation or improvement in ≈80% of such… Expand
  • 500
  • 8
  • PDF
Randomized Trial of Simple Versus Complex Drug-Eluting Stenting for Bifurcation Lesions: The British Bifurcation Coronary Study: Old, New, and Evolving Strategies
Background— The optimal strategy for treating coronary bifurcation lesions remains a subject of debate. With bare-metal stents, single-stent approaches appear to be superior to systematic 2-stent… Expand
  • 441
  • 7
Coronary flow reserve improves after aortic valve replacement for aortic stenosis: an adenosine transthoracic echocardiography study.
OBJECTIVES The goal of this study was to assess coronary flow reserve (CFR) before and after aortic valve replacement (AVR). BACKGROUND Coronary flow reserve is impaired under conditions of left… Expand
  • 109
  • 7
  • PDF
Transcatheter Aortic Valve Replacement in Pure Native Aortic Valve Regurgitation.
BACKGROUND Limited data exist about safety and efficacy of transcatheter aortic valve replacement (TAVR) in patients with pure native aortic regurgitation (AR). OBJECTIVES This study sought to… Expand
  • 92
  • 7